Hutchison China Meditech Limited operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hutchison China Meditech Limited with three other
miscellaneous service companies in Asia:
Takara Bio Inc
sales of 29.73 billion Japanese Yen [US$263.99 million]
of which 92%
was Bio support),
Shin Nippon Biomedical Laboratories Ltd
(14.75 billion Japanese Yen [US$130.98 million]
of which 80%
was Pre-Clinical Business), and
Syngene International Ltd
based in India
(11.07 billion Indian Rupees [US$169.37 million]
Hutchison China Meditech Limited reported sales of 1.44 billion Chinese Renmimbi (US$208.09 million)
December of 2016.
increase of 28.3%
versus 2015, when the company's sales were 1.12 billion Chinese Renmimbi.
This was the third consecutive year of growth at Hutchison China Meditech Limited.